Diuretics in the Management of Cardiorenal Syndrome

Publication date: September 2018Source: Advances in Chronic Kidney Disease, Volume 25, Issue 5Author(s): Chandrika Chitturi, James E. NovakThe leading cause of death worldwide is cardiovascular disease. The heart and the kidneys are functionally interdependent, such that dysfunction in one organ may cause dysfunction in the other. By one estimate, more than 60% of patients with congestive heart failure develop chronic kidney disease. Volume overload and congestion are hallmarks of heart failure, and these findings are associated with severe symptoms and poor outcomes. Given the importance of congestion, diuretics remain a cornerstone of heart failure management. However, diuretic treatment remains largely empirical, with little evidence currently available to guide decisions. In this review, we discuss the pathophysiology of cardiorenal syndrome, the pharmacology of loop diuretics, mechanisms of diuretic resistance, and evidence-based treatment paradigms.
Source: Advances in Chronic Kidney Disease - Category: Urology & Nephrology Source Type: research

Related Links:

This article reviews relationships between mild to moderate essential hypertension and chronic kidney disease with a focus on the role of APOL1 in development of hypertension. Available evidence strongly supports that APOL1 renal-risk variants associate with glomerulosclerosis in African Americans, which then causes secondary hypertension, not with essential hypertension per se.
Source: Advances in Chronic Kidney Disease - Category: Urology & Nephrology Source Type: research
AbstractPurposeFor early prevention, information regarding the incidence of major adverse cardiovascular events (MACEs) in middle-aged patients with chronic kidney disease (CKD) may be more beneficial than that regarding MACE prevalence. But, literature comparing the incidence and risk of MACEs in middle-aged patients with CKD with the controls using a population-based cohort study is scant. Our aim was to estimate the incidence and risk of MACEs, such as congestive heart failure (CHF) and ischemic heart disease (IHD), in middle-aged patients with advanced (stages 3 –5) CKD.MethodsFrom the National Health Insurance R...
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
Sara AlMarabeh, Mohammed H. Abdulla and Ken D. O'Halloran* Department of Physiology, School of Medicine, College of Medicine and Health, University College Cork, Cork, Ireland Renal sensory nerves are important in the regulation of body fluid and electrolyte homeostasis, and blood pressure. Activation of renal mechanoreceptor afferents triggers a negative feedback reno-renal reflex that leads to the inhibition of sympathetic nervous outflow. Conversely, activation of renal chemoreceptor afferents elicits reflex sympathoexcitation. Dysregulation of reno-renal reflexes by suppression of the inhibitory refle...
Source: Frontiers in Physiology - Category: Physiology Source Type: research
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
This cohort study was conducted between January 1, 2005, and December 31, 2009.
Source: Journal of Vascular Surgery - Category: Surgery Authors: Tags: Carotid endarterectomy should not be recommended for asymptomatic carotid stenosis in men with cancer in the past 5 years, moderate or severe chronic obstructive pulmonary disease, congestive heart failure, or chronic kidney disease Source Type: research
Authors: Sakashita M, Tanaka T, Nangaku M Abstract BACKGROUND: Hypoxia-inducible factor (HIF) stabilizers, also known as inhibitors of HIF prolyl hydroxylase domain (PHD) inhibitors enzymes, are novel small-molecule agents to treat renal anemia. They increase endogenous erythropoietin (EPO) production by stabilizing HIF. This review focuses on the mechanisms by which PHD inhibitors ameliorate anemia in chronic kidney disease (CKD) and summarizes the current clinical experience with and prospects for these drugs. SUMMARY: Anemia is a serious complication of CKD and is an independent risk factor for congestive he...
Source: Contributions to Nephrology - Category: Urology & Nephrology Tags: Contrib Nephrol Source Type: research
ConclusionsThese findings question a “one-size-fits-all” approach to fluid administration and performance measures for patients with sepsis.
Source: Journal of Critical Care - Category: Gastroenterology Source Type: research
Hypertension is the leading cause of death, premature morbidity, and disability-adjusted life years worldwide. Chronic hypertension is a predisposing factor to the development of coronary artery disease (CAD), cerebrovascular disease (CeVD), systemic atherosclerosis, congestive heart failure (CHF), chronic kidney disease (CKD) and dementia (1,2). Despite various regional and global efforts to control hypertension, its prevalence remains high and is estimated to impact more than 1.13 billion people worldwide (3).
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Šárka Vacková, Libor Kopkan, Soňa Kikerlová, Zuzana Husková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Bruce D. Hammock, John D. Imig, Miloš Táborský, Vojtěch Melenovský, Luděk Červenka
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
Dr Thomas S. Huber (Gainesville, Fla). The authors have analyzed the impact of preoperative anemia on the perioperative outcomes of both open and endovascular repair for intact aneurysms using the Vascular Quality Initiative. They have reported that anemia is associated with increased 30-day mortality and adverse outcome for endovascular but not open repair in their multivariate analysis. They reported that the adverse outcomes associated with anemia were independent of chronic kidney disease and congestive heart failure.
Source: Journal of Vascular Surgery - Category: Surgery Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Congestive Heart Failure | Drugs & Pharmacology | Heart | Heart Failure | Urology & Nephrology